|
La valeur du SRD à suivre : NicOx
|
La valeur du SRD à suivre : NicOx
Paris ouverture 18/03/11. NicOx vient de signer un accord avec Grupo Ferrer. Le groupe espagnol possède désormais une option de licence pour le Naproxcinod, un anti-inflammatoire de la société de biotechnologie française contre l’arthrose.
Video Length: 0
Date Found: March 18, 2011
Date Produced: March 18, 2011
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|